0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global API Drug Development Service Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-22H17346
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global API Drug Development Service Market Research Report 2024
BUY CHAPTERS

Global API Drug Development Service Market Research Report 2024

Code: QYRE-Auto-22H17346
Report
June 2024
Pages:95
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

API Drug Development Service Market

The global API Drug Development Service market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for API Drug Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for API Drug Development Service is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for API Drug Development Service in Small Biotechs Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of API Drug Development Service include Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for API Drug Development Service, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding API Drug Development Service.
The API Drug Development Service market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global API Drug Development Service market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the API Drug Development Service companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of API Drug Development Service Market Report

Report Metric Details
Report Name API Drug Development Service Market
Segment by Type
  • Captive Product Development Service
  • Commercial Product Development Service
Segment by Application
  • Small Biotechs Companies
  • Large Pharmaceutical Organizations
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, Pfizer, Axplora, Aptuit, Porton, Pharmaron Beijing, Shanghai Haoyuan Chemexpress, Stapharma
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of API Drug Development Service company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the API Drug Development Service Market report?

Ans: The main players in the API Drug Development Service Market are Lonza, Patheon, Catalent, Carbogen Amcis, Sterling Pharma Solutions, Cambrex, CordenPharma, Eurofins Scientific, Malvern Panalytical, Almac, Pfizer, Axplora, Aptuit, Porton, Pharmaron Beijing, Shanghai Haoyuan Chemexpress, Stapharma

What are the Application segmentation covered in the API Drug Development Service Market report?

Ans: The Applications covered in the API Drug Development Service Market report are Small Biotechs Companies, Large Pharmaceutical Organizations

What are the Type segmentation covered in the API Drug Development Service Market report?

Ans: The Types covered in the API Drug Development Service Market report are Captive Product Development Service, Commercial Product Development Service

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global API Drug Development Service Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Captive Product Development Service
1.2.3 Commercial Product Development Service
1.3 Market by Application
1.3.1 Global API Drug Development Service Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Small Biotechs Companies
1.3.3 Large Pharmaceutical Organizations
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global API Drug Development Service Market Perspective (2019-2030)
2.2 Global API Drug Development Service Growth Trends by Region
2.2.1 Global API Drug Development Service Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 API Drug Development Service Historic Market Size by Region (2019-2024)
2.2.3 API Drug Development Service Forecasted Market Size by Region (2025-2030)
2.3 API Drug Development Service Market Dynamics
2.3.1 API Drug Development Service Industry Trends
2.3.2 API Drug Development Service Market Drivers
2.3.3 API Drug Development Service Market Challenges
2.3.4 API Drug Development Service Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top API Drug Development Service Players by Revenue
3.1.1 Global Top API Drug Development Service Players by Revenue (2019-2024)
3.1.2 Global API Drug Development Service Revenue Market Share by Players (2019-2024)
3.2 Global API Drug Development Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by API Drug Development Service Revenue
3.4 Global API Drug Development Service Market Concentration Ratio
3.4.1 Global API Drug Development Service Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by API Drug Development Service Revenue in 2023
3.5 Global Key Players of API Drug Development Service Head office and Area Served
3.6 Global Key Players of API Drug Development Service, Product and Application
3.7 Global Key Players of API Drug Development Service, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 API Drug Development Service Breakdown Data by Type
4.1 Global API Drug Development Service Historic Market Size by Type (2019-2024)
4.2 Global API Drug Development Service Forecasted Market Size by Type (2025-2030)
5 API Drug Development Service Breakdown Data by Application
5.1 Global API Drug Development Service Historic Market Size by Application (2019-2024)
5.2 Global API Drug Development Service Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America API Drug Development Service Market Size (2019-2030)
6.2 North America API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America API Drug Development Service Market Size by Country (2019-2024)
6.4 North America API Drug Development Service Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe API Drug Development Service Market Size (2019-2030)
7.2 Europe API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe API Drug Development Service Market Size by Country (2019-2024)
7.4 Europe API Drug Development Service Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific API Drug Development Service Market Size (2019-2030)
8.2 Asia-Pacific API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
8.3 Asia-Pacific API Drug Development Service Market Size by Region (2019-2024)
8.4 Asia-Pacific API Drug Development Service Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America API Drug Development Service Market Size (2019-2030)
9.2 Latin America API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America API Drug Development Service Market Size by Country (2019-2024)
9.4 Latin America API Drug Development Service Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa API Drug Development Service Market Size (2019-2030)
10.2 Middle East & Africa API Drug Development Service Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa API Drug Development Service Market Size by Country (2019-2024)
10.4 Middle East & Africa API Drug Development Service Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Lonza
11.1.1 Lonza Company Details
11.1.2 Lonza Business Overview
11.1.3 Lonza API Drug Development Service Introduction
11.1.4 Lonza Revenue in API Drug Development Service Business (2019-2024)
11.1.5 Lonza Recent Development
11.2 Patheon
11.2.1 Patheon Company Details
11.2.2 Patheon Business Overview
11.2.3 Patheon API Drug Development Service Introduction
11.2.4 Patheon Revenue in API Drug Development Service Business (2019-2024)
11.2.5 Patheon Recent Development
11.3 Catalent
11.3.1 Catalent Company Details
11.3.2 Catalent Business Overview
11.3.3 Catalent API Drug Development Service Introduction
11.3.4 Catalent Revenue in API Drug Development Service Business (2019-2024)
11.3.5 Catalent Recent Development
11.4 Carbogen Amcis
11.4.1 Carbogen Amcis Company Details
11.4.2 Carbogen Amcis Business Overview
11.4.3 Carbogen Amcis API Drug Development Service Introduction
11.4.4 Carbogen Amcis Revenue in API Drug Development Service Business (2019-2024)
11.4.5 Carbogen Amcis Recent Development
11.5 Sterling Pharma Solutions
11.5.1 Sterling Pharma Solutions Company Details
11.5.2 Sterling Pharma Solutions Business Overview
11.5.3 Sterling Pharma Solutions API Drug Development Service Introduction
11.5.4 Sterling Pharma Solutions Revenue in API Drug Development Service Business (2019-2024)
11.5.5 Sterling Pharma Solutions Recent Development
11.6 Cambrex
11.6.1 Cambrex Company Details
11.6.2 Cambrex Business Overview
11.6.3 Cambrex API Drug Development Service Introduction
11.6.4 Cambrex Revenue in API Drug Development Service Business (2019-2024)
11.6.5 Cambrex Recent Development
11.7 CordenPharma
11.7.1 CordenPharma Company Details
11.7.2 CordenPharma Business Overview
11.7.3 CordenPharma API Drug Development Service Introduction
11.7.4 CordenPharma Revenue in API Drug Development Service Business (2019-2024)
11.7.5 CordenPharma Recent Development
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Details
11.8.2 Eurofins Scientific Business Overview
11.8.3 Eurofins Scientific API Drug Development Service Introduction
11.8.4 Eurofins Scientific Revenue in API Drug Development Service Business (2019-2024)
11.8.5 Eurofins Scientific Recent Development
11.9 Malvern Panalytical
11.9.1 Malvern Panalytical Company Details
11.9.2 Malvern Panalytical Business Overview
11.9.3 Malvern Panalytical API Drug Development Service Introduction
11.9.4 Malvern Panalytical Revenue in API Drug Development Service Business (2019-2024)
11.9.5 Malvern Panalytical Recent Development
11.10 Almac
11.10.1 Almac Company Details
11.10.2 Almac Business Overview
11.10.3 Almac API Drug Development Service Introduction
11.10.4 Almac Revenue in API Drug Development Service Business (2019-2024)
11.10.5 Almac Recent Development
11.11 Pfizer
11.11.1 Pfizer Company Details
11.11.2 Pfizer Business Overview
11.11.3 Pfizer API Drug Development Service Introduction
11.11.4 Pfizer Revenue in API Drug Development Service Business (2019-2024)
11.11.5 Pfizer Recent Development
11.12 Axplora
11.12.1 Axplora Company Details
11.12.2 Axplora Business Overview
11.12.3 Axplora API Drug Development Service Introduction
11.12.4 Axplora Revenue in API Drug Development Service Business (2019-2024)
11.12.5 Axplora Recent Development
11.13 Aptuit
11.13.1 Aptuit Company Details
11.13.2 Aptuit Business Overview
11.13.3 Aptuit API Drug Development Service Introduction
11.13.4 Aptuit Revenue in API Drug Development Service Business (2019-2024)
11.13.5 Aptuit Recent Development
11.14 Porton
11.14.1 Porton Company Details
11.14.2 Porton Business Overview
11.14.3 Porton API Drug Development Service Introduction
11.14.4 Porton Revenue in API Drug Development Service Business (2019-2024)
11.14.5 Porton Recent Development
11.15 Pharmaron Beijing
11.15.1 Pharmaron Beijing Company Details
11.15.2 Pharmaron Beijing Business Overview
11.15.3 Pharmaron Beijing API Drug Development Service Introduction
11.15.4 Pharmaron Beijing Revenue in API Drug Development Service Business (2019-2024)
11.15.5 Pharmaron Beijing Recent Development
11.16 Shanghai Haoyuan Chemexpress
11.16.1 Shanghai Haoyuan Chemexpress Company Details
11.16.2 Shanghai Haoyuan Chemexpress Business Overview
11.16.3 Shanghai Haoyuan Chemexpress API Drug Development Service Introduction
11.16.4 Shanghai Haoyuan Chemexpress Revenue in API Drug Development Service Business (2019-2024)
11.16.5 Shanghai Haoyuan Chemexpress Recent Development
11.17 Stapharma
11.17.1 Stapharma Company Details
11.17.2 Stapharma Business Overview
11.17.3 Stapharma API Drug Development Service Introduction
11.17.4 Stapharma Revenue in API Drug Development Service Business (2019-2024)
11.17.5 Stapharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global API Drug Development Service Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
 Table 2. Key Players of Captive Product Development Service
 Table 3. Key Players of Commercial Product Development Service
 Table 4. Global API Drug Development Service Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
 Table 5. Global API Drug Development Service Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
 Table 6. Global API Drug Development Service Market Size by Region (2019-2024) & (US$ Million)
 Table 7. Global API Drug Development Service Market Share by Region (2019-2024)
 Table 8. Global API Drug Development Service Forecasted Market Size by Region (2025-2030) & (US$ Million)
 Table 9. Global API Drug Development Service Market Share by Region (2025-2030)
 Table 10. API Drug Development Service Market Trends
 Table 11. API Drug Development Service Market Drivers
 Table 12. API Drug Development Service Market Challenges
 Table 13. API Drug Development Service Market Restraints
 Table 14. Global API Drug Development Service Revenue by Players (2019-2024) & (US$ Million)
 Table 15. Global API Drug Development Service Market Share by Players (2019-2024)
 Table 16. Global Top API Drug Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in API Drug Development Service as of 2023)
 Table 17. Ranking of Global Top API Drug Development Service Companies by Revenue (US$ Million) in 2023
 Table 18. Global 5 Largest Players Market Share by API Drug Development Service Revenue (CR5 and HHI) & (2019-2024)
 Table 19. Global Key Players of API Drug Development Service, Headquarters and Area Served
 Table 20. Global Key Players of API Drug Development Service, Product and Application
 Table 21. Global Key Players of API Drug Development Service, Date of Enter into This Industry
 Table 22. Mergers & Acquisitions, Expansion Plans
 Table 23. Global API Drug Development Service Market Size by Type (2019-2024) & (US$ Million)
 Table 24. Global API Drug Development Service Revenue Market Share by Type (2019-2024)
 Table 25. Global API Drug Development Service Forecasted Market Size by Type (2025-2030) & (US$ Million)
 Table 26. Global API Drug Development Service Revenue Market Share by Type (2025-2030)
 Table 27. Global API Drug Development Service Market Size by Application (2019-2024) & (US$ Million)
 Table 28. Global API Drug Development Service Revenue Market Share by Application (2019-2024)
 Table 29. Global API Drug Development Service Forecasted Market Size by Application (2025-2030) & (US$ Million)
 Table 30. Global API Drug Development Service Revenue Market Share by Application (2025-2030)
 Table 31. North America API Drug Development Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 32. North America API Drug Development Service Market Size by Country (2019-2024) & (US$ Million)
 Table 33. North America API Drug Development Service Market Size by Country (2025-2030) & (US$ Million)
 Table 34. Europe API Drug Development Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 35. Europe API Drug Development Service Market Size by Country (2019-2024) & (US$ Million)
 Table 36. Europe API Drug Development Service Market Size by Country (2025-2030) & (US$ Million)
 Table 37. Asia-Pacific API Drug Development Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 38. Asia-Pacific API Drug Development Service Market Size by Region (2019-2024) & (US$ Million)
 Table 39. Asia-Pacific API Drug Development Service Market Size by Region (2025-2030) & (US$ Million)
 Table 40. Latin America API Drug Development Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 41. Latin America API Drug Development Service Market Size by Country (2019-2024) & (US$ Million)
 Table 42. Latin America API Drug Development Service Market Size by Country (2025-2030) & (US$ Million)
 Table 43. Middle East & Africa API Drug Development Service Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
 Table 44. Middle East & Africa API Drug Development Service Market Size by Country (2019-2024) & (US$ Million)
 Table 45. Middle East & Africa API Drug Development Service Market Size by Country (2025-2030) & (US$ Million)
 Table 46. Lonza Company Details
 Table 47. Lonza Business Overview
 Table 48. Lonza API Drug Development Service Product
 Table 49. Lonza Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 50. Lonza Recent Development
 Table 51. Patheon Company Details
 Table 52. Patheon Business Overview
 Table 53. Patheon API Drug Development Service Product
 Table 54. Patheon Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 55. Patheon Recent Development
 Table 56. Catalent Company Details
 Table 57. Catalent Business Overview
 Table 58. Catalent API Drug Development Service Product
 Table 59. Catalent Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 60. Catalent Recent Development
 Table 61. Carbogen Amcis Company Details
 Table 62. Carbogen Amcis Business Overview
 Table 63. Carbogen Amcis API Drug Development Service Product
 Table 64. Carbogen Amcis Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 65. Carbogen Amcis Recent Development
 Table 66. Sterling Pharma Solutions Company Details
 Table 67. Sterling Pharma Solutions Business Overview
 Table 68. Sterling Pharma Solutions API Drug Development Service Product
 Table 69. Sterling Pharma Solutions Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 70. Sterling Pharma Solutions Recent Development
 Table 71. Cambrex Company Details
 Table 72. Cambrex Business Overview
 Table 73. Cambrex API Drug Development Service Product
 Table 74. Cambrex Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 75. Cambrex Recent Development
 Table 76. CordenPharma Company Details
 Table 77. CordenPharma Business Overview
 Table 78. CordenPharma API Drug Development Service Product
 Table 79. CordenPharma Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 80. CordenPharma Recent Development
 Table 81. Eurofins Scientific Company Details
 Table 82. Eurofins Scientific Business Overview
 Table 83. Eurofins Scientific API Drug Development Service Product
 Table 84. Eurofins Scientific Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 85. Eurofins Scientific Recent Development
 Table 86. Malvern Panalytical Company Details
 Table 87. Malvern Panalytical Business Overview
 Table 88. Malvern Panalytical API Drug Development Service Product
 Table 89. Malvern Panalytical Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 90. Malvern Panalytical Recent Development
 Table 91. Almac Company Details
 Table 92. Almac Business Overview
 Table 93. Almac API Drug Development Service Product
 Table 94. Almac Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 95. Almac Recent Development
 Table 96. Pfizer Company Details
 Table 97. Pfizer Business Overview
 Table 98. Pfizer API Drug Development Service Product
 Table 99. Pfizer Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 100. Pfizer Recent Development
 Table 101. Axplora Company Details
 Table 102. Axplora Business Overview
 Table 103. Axplora API Drug Development Service Product
 Table 104. Axplora Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 105. Axplora Recent Development
 Table 106. Aptuit Company Details
 Table 107. Aptuit Business Overview
 Table 108. Aptuit API Drug Development Service Product
 Table 109. Aptuit Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 110. Aptuit Recent Development
 Table 111. Porton Company Details
 Table 112. Porton Business Overview
 Table 113. Porton API Drug Development Service Product
 Table 114. Porton Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 115. Porton Recent Development
 Table 116. Pharmaron Beijing Company Details
 Table 117. Pharmaron Beijing Business Overview
 Table 118. Pharmaron Beijing API Drug Development Service Product
 Table 119. Pharmaron Beijing Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 120. Pharmaron Beijing Recent Development
 Table 121. Shanghai Haoyuan Chemexpress Company Details
 Table 122. Shanghai Haoyuan Chemexpress Business Overview
 Table 123. Shanghai Haoyuan Chemexpress API Drug Development Service Product
 Table 124. Shanghai Haoyuan Chemexpress Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 125. Shanghai Haoyuan Chemexpress Recent Development
 Table 126. Stapharma Company Details
 Table 127. Stapharma Business Overview
 Table 128. Stapharma API Drug Development Service Product
 Table 129. Stapharma Revenue in API Drug Development Service Business (2019-2024) & (US$ Million)
 Table 130. Stapharma Recent Development
 Table 131. Research Programs/Design for This Report
 Table 132. Key Data Information from Secondary Sources
 Table 133. Key Data Information from Primary Sources
 Table 134. Authors List of This Report


List of Figures
 Figure 1. API Drug Development Service Picture
 Figure 2. Global API Drug Development Service Market Size Comparison by Type (2024-2030) & (US$ Million)
 Figure 3. Global API Drug Development Service Market Share by Type: 2023 VS 2030
 Figure 4. Captive Product Development Service Features
 Figure 5. Commercial Product Development Service Features
 Figure 6. Global API Drug Development Service Market Size by Application (2024-2030) & (US$ Million)
 Figure 7. Global API Drug Development Service Market Share by Application: 2023 VS 2030
 Figure 8. Small Biotechs Companies Case Studies
 Figure 9. Large Pharmaceutical Organizations Case Studies
 Figure 10. API Drug Development Service Report Years Considered
 Figure 11. Global API Drug Development Service Market Size (US$ Million), Year-over-Year: 2019-2030
 Figure 12. Global API Drug Development Service Market Size, (US$ Million), 2019 VS 2023 VS 2030
 Figure 13. Global API Drug Development Service Market Share by Region: 2023 VS 2030
 Figure 14. Global API Drug Development Service Market Share by Players in 2023
 Figure 15. Global Top API Drug Development Service Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in API Drug Development Service as of 2023)
 Figure 16. The Top 10 and 5 Players Market Share by API Drug Development Service Revenue in 2023
 Figure 17. North America API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 18. North America API Drug Development Service Market Share by Country (2019-2030)
 Figure 19. United States API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 20. Canada API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 21. Europe API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 22. Europe API Drug Development Service Market Share by Country (2019-2030)
 Figure 23. Germany API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 24. France API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 25. U.K. API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 26. Italy API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 27. Russia API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 28. Nordic Countries API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 29. Asia-Pacific API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 30. Asia-Pacific API Drug Development Service Market Share by Region (2019-2030)
 Figure 31. China API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 32. Japan API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 33. South Korea API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 34. Southeast Asia API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 35. India API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 36. Australia API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 37. Latin America API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 38. Latin America API Drug Development Service Market Share by Country (2019-2030)
 Figure 39. Mexico API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 40. Brazil API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 41. Middle East & Africa API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 42. Middle East & Africa API Drug Development Service Market Share by Country (2019-2030)
 Figure 43. Turkey API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 44. Saudi Arabia API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 45. UAE API Drug Development Service Market Size YoY Growth (2019-2030) & (US$ Million)
 Figure 46. Lonza Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 47. Patheon Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 48. Catalent Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 49. Carbogen Amcis Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 50. Sterling Pharma Solutions Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 51. Cambrex Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 52. CordenPharma Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 53. Eurofins Scientific Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 54. Malvern Panalytical Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 55. Almac Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 56. Pfizer Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 57. Axplora Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 58. Aptuit Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 59. Porton Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 60. Pharmaron Beijing Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 61. Shanghai Haoyuan Chemexpress Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 62. Stapharma Revenue Growth Rate in API Drug Development Service Business (2019-2024)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Strategic Venue Partners

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart